InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
40%
T+90 mean return
+1.4%
Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by KASINGER JAMES R., Conseiller Juridique Général et Secrétaire. Director active across 1 company, notably CRISPR Therapeutics AG. In total, 16 reports have been published. Activity tracked since 2 December 2021. The latest transaction was filed on 2 December 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations16 total
6,250 sharesCommon SharesSEC:0000950170-25-043972:0
5,500 sharesCommon SharesSEC:0000950170-25-038215:0
20,000 sharesCommon SharesSEC:0000950170-25-023386:0
2,113 sharesCommon SharesSEC:0000950170-24-114787:0
5,500 sharesCommon SharesSEC:0000950170-24-030190:0
3,825 sharesCommon SharesSEC:0000950170-24-018175:0
2,833 sharesCommon SharesSEC:0001209191-23-018564:0
3,825 sharesCommon SharesSEC:0001209191-23-011777:0
6,667 sharesCommon SharesSEC:0001209191-22-060090:0
2,834 sharesCommon SharesSEC:0001209191-22-018609:0
13,333 sharesCommon SharesSEC:0001209191-21-068453:0
13,333 sharesCommon SharesSEC:0001209191-21-068453
7,342 shares@ US$13.6250.0% of flowCommon SharesSEC:0001209191-21-068014
7,342 shares@ US$13.620.0019% mcap50.0% of flowCommon SharesSEC:0001209191-21-068014:0
10,000 sharesCommon SharesSEC:0001209191-21-056093
10,000 sharesCommon SharesSEC:0001209191-21-056093:0
16 of 16 declarations
About KASINGER JAMES R.
James R. Kasinger is the General Counsel and Secretary at CRISPR Therapeutics AG. He is responsible for managing the company's legal affairs. With expertise in business law, he plays a key role in protecting the company's legal interests. James R. Kasinger is committed to supporting the company's mission while ensuring legal compliance.
